Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
| Form | Size | Price | $/mg | Stock | Updated |
|---|---|---|---|---|---|
| vial | 5mg | $24.99 | $5.00/mg | Out of stock | Jun 1 |
| vial | 10mg | $34.99 | $3.50/mg | Out of stock | Jun 1 |
| vial | 15mg | $49.99 | $3.33/mg | Out of stock | Jun 1 |
Single-vial list prices — bulk or bundle orders may be lower. Verify at vendor before purchase.
| Lot / Report | Tested | Purity | Lab | Panels | Status | |
|---|---|---|---|---|---|---|
| BPC10-1160 | Nov 2025 | — | Freedom Diagnostics | Endotoxin | Confirmed | View |
The FDA PCAC advisory committee meets July 23–24, 2026 to review nominations and make recommendations on compounding eligibility — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. BPC-157 is on the proposed list. If the FDA subsequently issues a final rule, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Disclosed Labs does not provide medical or legal advice.
Does Peptide Tech sell BPC-157?
Yes — Peptide Tech currently lists BPC-157 in 3 variants starting at $49.99 ($3.33/mg).
Is Peptide Tech's BPC-157 third-party tested?
Yes — Disclosed Labs has indexed 13 Certificates of Analysis for Peptide Tech's BPC-157, with the most recent showing 98.4% purity. Peptide Tech holds an overall trust grade of C (78/100) across all 219 COAs on file.
What is Peptide Tech's trust grade for BPC-157?
Peptide Tech has an overall Disclosed Labs trust grade of C (78/100), computed from 219 COAs across all peptides. The most recent BPC-157 COA was issued by Freedom Diagnostics.
Where is the cheapest BPC-157?
As of the latest data, Alpha Peptides offers BPC-157 at $1.82/mg — compare with Peptide Tech's listing at $3.33/mg. See the full BPC-157 price comparison.
Is BPC-157 legal to buy?
BPC-157 is among the peptides under FDA review for the Category 1 (503A) bulk-substances list — removed from Category 2 in April 2026 but not yet on a finalized Category 1 list. The FDA PCAC committee meets July 23–24, 2026 to make recommendations on which peptides may be compounded, and under what conditions — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. If a final rule is ultimately issued, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Current sales are for research purposes only. Disclosed Labs does not provide medical or legal advice.
| BPC15-9680 | Nov 2025 | — | Freedom Diagnostics | Endotoxin | Confirmed | View |
| BPC10-1154 | Oct 2025 | — | Freedom Diagnostics | Endotoxin | Confirmed | View |
| BPC5-4115 | Oct 2025 | — | Freedom Diagnostics | Endotoxin | Confirmed | View |
| — | Sep 2025 | 98.4% | Chromate | — | Confirmed | View |
| 137525-51-0 | Apr 2025 | 99.1% | SafeCert Labs | — | Unverified | View |
| BC10-001 | Mar 2025 | 99.4% | Janoshik Analytical | Endotoxin | Unverified | View |
| 394894 | Feb 2025 | 99.0% | SafeCert Labs | — | Unverified | View |
| 394892 | Feb 2025 | 99.2% | SafeCert Labs | — | Unverified | View |
| BC5-001 | Nov 2024 | 99.0% | Janoshik Analytical | — | Unverified | View |
| — | Sep 2024 | 99.2% | Janoshik Analytical | — | Unverified | View |
| 2024-05-06 | Jun 2024 | 99.9% | MZ Biolabs | — | Unverified | View |
| 394893 | — | 98.7% | SafeCert Labs | — | Unverified | View |
Disclosed Labs